Cardiopulmonary arrest caused by nafamostat mesylate during hemodialysis

Abstract

Abstract Dialysis‐related adverse reactions can be serious and difficult to predict. In our case, nafamostat mesylate (NM) was thought to be the cause of cardiopulmonary arrest (CPA) due to NM‐induced anaphylaxis but was not reflected in the allergy tests. Rare but life‐threatening drawbacks occur immediately after hemodialysis initiation.

Keywords

• and anaphylaxis
• cardiopulmonary arrest
• dialysis‐related adverse reactions
• hemodialysis
• nafamostat mesylate